We found a relatively faster increase of p‐tau181, NfL, GFAP, and p‐tau181/Aβ42 and faster decrease of Aβ42/Aβ40 in incident MCI/AD compared to CU participants; however, the results were not significant (Table 4). The gene discussed is GFAP; the disease is Alzheimer disease.